Effective x-ray attenuation measurements with full field digital mammography.

This work shows that effective x-ray attenuation coefficients may be estimated by applying Beer's Law to phantom image data acquired with the General Electric Senographe 2000D full field digital mammography system. Theoretical developments are provided indicating that an approximate form of the Beer's relation holds for polychromatic x-ray beams. The theoretical values were compared with experimentally determined measured values, which were estimated at various detector locations. The measured effective attenuation coefficients are in agreement with those estimated with theoretical developments and numerical integration. The work shows that the measured quantities show little spatial variation. The main ideas are demonstrated with polymethylmethacrylate and breast tissue equivalent phantom imaging experiments. The work suggests that the effective attenuation coefficients may be used as known values for radiometric standardization applications that compensate for the image acquisition influences. The work indicates that it is possible to make quantitative attenuation coefficient measurements from a system designed for clinical purposes.

[1]  I. Gram,et al.  Percentage density, Wolfe's and Tabár's mammographic patterns: agreement and association with risk factors for breast cancer , 2005, Breast Cancer Research.

[2]  Bianca De Stavola,et al.  Mammographic Features and Subsequent Risk of Breast Cancer: A Comparison of Qualitative and Quantitative Evaluations in the Guernsey Prospective Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[3]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[4]  N. Boyd,et al.  Analysis of mammographic density and breast cancer risk from digitized mammograms. , 1998, Radiographics : a review publication of the Radiological Society of North America, Inc.

[5]  A. Oza,et al.  Mammographic parenchymal patterns: a marker of breast cancer risk. , 1993, Epidemiologic reviews.

[6]  J. Brisson,et al.  Tamoxifen and mammographic breast densities. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  G. Maskarinec,et al.  A 2-year soy intervention in premenopausal women does not change mammographic densities. , 2004, The Journal of nutrition.

[8]  N. Boyd,et al.  Risk factors for breast cancer associated with mammographic features in Singaporean chinese women. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  B. Geller,et al.  A prospective study of breast cancer risk using routine mammographic breast density measurements. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[10]  S. Cummings,et al.  Mammographic Breast Density and the Gail Model for Breast Cancer Risk Prediction in a Screening Population , 2005, Breast Cancer Research and Treatment.

[11]  M. Yaffe,et al.  Insulin-Like Growth Factor-I, IGF-Binding Protein-3, and Mammographic Breast Density , 2005, Cancer Epidemiology Biomarkers & Prevention.

[12]  J. Wolfe Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.

[13]  Boubaker Zarrad,et al.  Computation of beam quality parameters for Mo/Mo, Mo/Rh, Rh/Rh, and W/Al target/filter combinations in mammography. , 2003, Medical physics.

[14]  K. Griffith,et al.  Correlates of mammogram density in southwestern Native-American women. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  Jennifer Couzin Dissecting a Hidden Breast Cancer Risk , 2005, Science.

[16]  Peter H Watson,et al.  Mammographic density is related to stroma and stromal proteoglycan expression , 2003, Breast Cancer Research.

[17]  Malcolm C Pike,et al.  Mammographic density and breast cancer in three ethnic groups. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  M J Yaffe,et al.  X-ray characterization of breast phantom materials. , 1998, Physics in medicine and biology.

[19]  J. Wolfe Risk for breast cancer development determined by mammographic parenchymal pattern , 1976, Cancer.

[20]  D. Grobbee,et al.  Measurements of Breast Density: No Ratio for a Ratio , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  I. Gram,et al.  Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[22]  Emily White,et al.  Association between Mammographic Breast Density and Breast Cancer Tumor Characteristics , 2005, Cancer Epidemiology Biomarkers & Prevention.

[23]  J. Kaufhold,et al.  A calibration approach to glandular tissue composition estimation in digital mammography. , 2002, Medical physics.

[24]  A. Paterson,et al.  Mammographic breast density as an intermediate phenotype for breast cancer. , 2005, The Lancet. Oncology.

[25]  M. Yaffe,et al.  Levels of C-Peptide and Mammographic Breast Density , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  Jennifer A Harvey,et al.  Quantitative assessment of mammographic breast density: relationship with breast cancer risk. , 2004, Radiology.

[27]  L. Kuller,et al.  Breast cancer risk factors and mammographic breast density in women over age 70 , 2006, Breast Cancer Research and Treatment.

[28]  J. S. Laughlin,et al.  Absorbed radiation dose in mammography. , 1979, Radiology.

[29]  D. Venzon,et al.  Effect of tamoxifen on mammographic density. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  P. C. Johns,et al.  X-ray characterisation of normal and neoplastic breast tissues. , 1987, Physics in medicine and biology.

[31]  W. Willett,et al.  Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. , 2000, Cancer research.

[32]  Dan Rico,et al.  A volumetric method for estimation of breast density on digitized screen-film mammograms. , 2003, Medical physics.

[33]  S Suryanarayanan,et al.  Full breast digital mammography with an amorphous silicon-based flat panel detector: physical characteristics of a clinical prototype. , 2000, Medical physics.

[34]  N. Boyd,et al.  Pituitary Growth Hormone and Growth Hormone–Releasing Hormone Receptor Genes and Associations with Mammographic Measures and Serum Growth Hormone , 2005, Cancer Epidemiology Biomarkers & Prevention.

[35]  S. Cummings,et al.  Mammographic density and estrogen receptor status of breast cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  T. R. Fewell,et al.  Molybdenum, rhodium, and tungsten anode spectral models using interpolating polynomials with application to mammography. , 1997, Medical physics.

[37]  B. Archer,et al.  On the measurement of half-value layer in film-screen mammography. , 1990, Medical physics.

[38]  C M Rutter,et al.  Changes in breast density associated with initiation, discontinuation, and continuing use of hormone replacement therapy. , 2001, JAMA.

[39]  Thomas Oshiro,et al.  Evaluation of detector dynamic range in the x-ray exposure domain in mammography: a comparison between film-screen and flat panel detector systems. , 2003, Medical physics.

[40]  John J Heine,et al.  Spectral analysis of full field digital mammography data. , 2002, Medical physics.

[41]  J. Wolfe Breast parenchymal patterns and their changes with age. , 1976, Radiology.

[42]  E. Fishell,et al.  Mammographic patterns and breast cancer risk: methodologic standards and contradictory results. , 1984, Journal of the National Cancer Institute.

[43]  John N. Wolfe,et al.  Mammography: Ducts as a Sole Indicator of Breast Carcinoma1 , 1967 .

[44]  G. Jasienska,et al.  Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[46]  M. Yaffe,et al.  A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  Russell Davies,et al.  Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2006, Cancer research.

[48]  G. Colditz,et al.  Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[49]  R. Baumgartner,et al.  Pre-diagnosis physical activity and mammographic density in breast cancer survivors , 2005, Breast Cancer Research and Treatment.

[50]  Karla Kerlikowske,et al.  Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.